Hai-Peng Xu (Haipeng Xu)

Publication Activity (10 Years)

Years Active: 2017-2020
Publications (10 Years): 5

Top Topics

Small Cell Lung Cancer

Tyrosine Kinase

Endoplasmic Reticulum Stress

Epidermal Growth Factor Receptor

Top Venues

OncoTargets and therapy

Cancer management and research

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Hai-Peng Xu, Lin Dong, Zhang Bin, Huo Yansong, Lin Shaofeng, Liu Chang, Chen Chen, Wang Changli
Supramolecular self-assembly of a hybrid 'hyalurosome' for targeted photothermal therapy in non-small cell lung cancer. Drug delivery 27 (1) (2020)
Qiang Wang, Jinrong Liao, Zhiyong He, Ying Su, Dong Lin, Ling Xu, Hai-Peng Xu, Jinghui Lin
LHX6 Affects Erlotinib Resistance and Migration of EGFR-Mutant Non-Small-Cell Lung Cancer HCC827 Cells Through Suppressing Wnt/β-Catenin Signaling. OncoTargets and therapy 13 (2020)
Ming-Fan Ye, Dong Lin, Wu-Jin Li, Hai-Peng Xu, Jing Zhang
MiR-26a-5p Serves as an Oncogenic MicroRNA in Non-Small Cell Lung Cancer by Targeting FAF1. Cancer management and research 12 (2020)
Hai-Peng Xu, Xueyan Chen, Dong Lin, Jing Zhang, Chao Li, Dianbao Zhang, Xianfen Zhang
Conformance Assessment of PD-L1 Expression Between Primary Tumour and Nodal Metastases in Non-Small-Cell Lung Cancer. OncoTargets and therapy 12 (2019)
Hai-Peng Xu, Gen Lin, Cheng Huang, Weifeng Zhu, Qian Miao, Xirong Fan, Biao Wu, Xiaobing Zheng, Xiandong Lin, Kan Jiang, Dan Hu, Chao Li
Assessment of Concordance between 22C3 and SP142 Immunohistochemistry Assays regarding PD-L1 Expression in Non-Small Cell Lung Cancer. Scientific reports 7 (1) (2017)